Literature DB >> 31455587

Timeliness of rotavirus vaccination at sentinel sites in four early-adopter African countries.

Talia Pindyck1, Jacqueline E Tate2, Isidore Juste O Bonkoungou3, George Armah4, Hilda Angela Mujuru5, Celse Rugambwa6, Jason M Mwenda7, Umesh Parashar2.   

Abstract

BACKGROUND: The majority of countries with the highest rotavirus-associated death rates are in sub-Saharan Africa. In 2009, the World Health Organization (WHO) recommended routine vaccination against rotavirus worldwide, with unique age recommendations to administer the first dose before 15 weeks of age and last dose by 32 weeks of age. These age restrictions were relaxed in January 2013, but they may still lead to lower rotavirus vaccine coverage.
METHODS: Children age-eligible to have received rotavirus vaccine that were enrolled in Ghana, Zimbabwe, Rwanda or Burkina Faso's active rotavirus surveillance platforms from 2013 to 2017 and had a stool specimen that tested rotavirus-negative were included in the analysis. Proportion vaccinated and timeliness of rotavirus vaccine versus DTPw-HepB-Hib (pentavalent) first dose and last dose were compared at weeks 15 and 32, respectively, using Chi-square analyses. Odds ratios were calculated using logistic regression.
RESULTS: Among children who received rotavirus vaccine dose 1, 96-99% received this dose by 15 weeks of age and among children who received the last dose, 98-99% received it by 32 weeks of age. In all four countries, there was no significant difference in the proportion of children who received first dose rotavirus versus pentavalent vaccine by week 15, or last dose rotavirus versus concordant pentavalent vaccine by week 32. Delayed administration of first dose pentavalent vaccine was significantly associated with missing first dose of rotavirus vaccine in 3 of the 4 countries studied, although delays in administration were rare (1-4%).
CONCLUSIONS: Rotavirus vaccination was timely among sentinel sites in these four early rotavirus vaccine-introducing countries in Africa. Late presentation for vaccination may have resulted in some children with access to care missing first dose of rotavirus vaccine; however, vaccination delays were infrequent and therefore the potential impact of the age restrictions on overall proportion vaccinated was minimal. Published by Elsevier Ltd.

Entities:  

Keywords:  Acute gastroenteritis; Methods; Surveillance; Validation

Mesh:

Substances:

Year:  2019        PMID: 31455587      PMCID: PMC9153147          DOI: 10.1016/j.vaccine.2019.08.008

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   4.169


  8 in total

1.  Rotavirus vaccines:an update.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2009-12-18

2.  Rotavirus vaccines. WHO position paper – January 2013.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2013-02-01

3.  Reduction in Diarrhea- and Rotavirus-related Healthcare Visits Among Children <5 Years of Age After National Rotavirus Vaccine Introduction in Zimbabwe.

Authors:  Hilda A Mujuru; Catherine Yen; Kusum J Nathoo; Nhamo A Gonah; Ismail Ticklay; Arnold Mukaratirwa; Chipo Berejena; Ottias Tapfumanei; Kenneth Chindedza; Maxwell Rupfutse; Goitom Weldegebriel; Jason M Mwenda; Eleanor Burnett; Jacqueline E Tate; Umesh D Parashar; Portia Manangazira
Journal:  Pediatr Infect Dis J       Date:  2017-10       Impact factor: 2.129

4.  Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda.

Authors:  Jacqueline E Tate; Fidele Ngabo; Philippe Donnen; Maurice Gatera; Jeannine Uwimana; Celse Rugambwa; Jason M Mwenda; Umesh D Parashar
Journal:  Clin Infect Dis       Date:  2016-05-01       Impact factor: 9.079

5.  Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000-2013.

Authors:  Jacqueline E Tate; Anthony H Burton; Cynthia Boschi-Pinto; Umesh D Parashar
Journal:  Clin Infect Dis       Date:  2016-05-01       Impact factor: 9.079

6.  Impact and Effectiveness of Monovalent Rotavirus Vaccine Against Severe Rotavirus Diarrhea in Ghana.

Authors:  George Armah; Kimberly Pringle; Christabel C Enweronu-Laryea; Daniel Ansong; Jason M Mwenda; Stanley K Diamenu; Clement Narh; Belinda Lartey; Fred Binka; Scott Grytdal; Manish Patel; Umesh Parashar; Ben Lopman
Journal:  Clin Infect Dis       Date:  2016-05-01       Impact factor: 9.079

7.  Impact and effectiveness of pentavalent rotavirus vaccine in children <5 years of age in Burkina Faso.

Authors:  Isidore Juste O Bonkoungou; Negar Aliabadi; Eyal Leshem; Madibèlè Kam; Désiré Nezien; Maxime K Drabo; Moumouni Nikiema; Boureima Ouedraogo; Isaïe Medah; Souleymane Konaté; Rasmata Ouédraogo-Traoré; Lassana Sangaré; Ludovic Kam; Diarra Yé; Ma Ouattara; Joseph N Biey; Jason M Mwenda; Jacqueline E Tate; Umesh D Parashar
Journal:  Vaccine       Date:  2017-12-28       Impact factor: 4.169

8.  Rotavirus vaccine effectiveness in low-income settings: An evaluation of the test-negative design.

Authors:  Lauren M Schwartz; M Elizabeth Halloran; Ali Rowhani-Rahbar; Kathleen M Neuzil; John C Victor
Journal:  Vaccine       Date:  2016-11-18       Impact factor: 3.641

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.